Financials Resonance Health Limited
Equities
RHT
AU000000RHT2
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 AUD | 0.00% | +4.94% | +41.67% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 9.66 | 44.36 | 66.57 | 71.48 | 25.82 | 19.37 |
Enterprise Value (EV) 1 | 8.111 | 41.28 | 59.71 | 62.68 | 19.31 | 13.28 |
P/E ratio | 43 x | 33.9 x | -88.2 x | 119 x | -22.4 x | -24.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.34 x | 12.2 x | 18.1 x | 18.9 x | 6.7 x | 4.33 x |
EV / Revenue | 2.8 x | 11.4 x | 16.3 x | 16.6 x | 5.01 x | 2.97 x |
EV / EBITDA | -72.4 x | 39.5 x | -63.2 x | 144 x | -13 x | -10.1 x |
EV / FCF | -14 x | 63 x | 51 x | 172 x | -10.9 x | -30.1 x |
FCF Yield | -7.13% | 1.59% | 1.96% | 0.58% | -9.21% | -3.32% |
Price to Book | 2.34 x | 7.53 x | 6.72 x | 6.04 x | 2.42 x | 1.95 x |
Nbr of stocks (in thousands) | 402,498 | 422,498 | 443,774 | 461,150 | 461,150 | 461,150 |
Reference price 2 | 0.0240 | 0.1050 | 0.1500 | 0.1550 | 0.0560 | 0.0420 |
Announcement Date | 9/13/18 | 9/27/19 | 9/30/20 | 9/29/21 | 9/29/22 | 8/29/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.896 | 3.625 | 3.668 | 3.779 | 3.853 | 4.471 |
EBITDA 1 | -0.112 | 1.045 | -0.9446 | 0.4364 | -1.491 | -1.32 |
EBIT 1 | -0.1389 | 1.021 | -0.964 | 0.4173 | -1.525 | -1.36 |
Operating Margin | -4.8% | 28.18% | -26.28% | 11.04% | -39.57% | -30.42% |
Earnings before Tax (EBT) 1 | -0.2273 | 0.9417 | -0.9527 | 0.3435 | -1.552 | -1.264 |
Net income 1 | 0.2246 | 1.27 | -0.7151 | 0.5859 | -1.142 | -0.7804 |
Net margin | 7.76% | 35.05% | -19.49% | 15.5% | -29.63% | -17.45% |
EPS 2 | 0.000558 | 0.003099 | -0.001700 | 0.001299 | -0.002499 | -0.001699 |
Free Cash Flow 1 | -0.5787 | 0.6549 | 1.17 | 0.3635 | -1.778 | -0.4409 |
FCF margin | -19.98% | 18.07% | 31.9% | 9.62% | -46.14% | -9.86% |
FCF Conversion (EBITDA) | - | 62.66% | - | 83.31% | - | - |
FCF Conversion (Net income) | - | 51.56% | - | 62.05% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/13/18 | 9/27/19 | 9/30/20 | 9/29/21 | 9/29/22 | 8/29/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 1.55 | 3.08 | 6.86 | 8.8 | 6.51 | 6.09 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.58 | 0.65 | 1.17 | 0.36 | -1.78 | -0.44 |
ROE (net income / shareholders' equity) | 5.71% | 25.3% | -9.05% | 5.39% | -10.1% | -7.57% |
ROA (Net income/ Total Assets) | -1.87% | 11.5% | -7.12% | 2.27% | -7.9% | -7.5% |
Assets 1 | -12.04 | 11.05 | 10.04 | 25.76 | 14.45 | 10.4 |
Book Value Per Share 2 | 0.0100 | 0.0100 | 0.0200 | 0.0300 | 0.0200 | 0.0200 |
Cash Flow per Share 2 | 0 | 0.0100 | 0.0200 | 0.0200 | 0.0100 | 0.0100 |
Capex 1 | 0.01 | 0 | 0 | 0.04 | 0.12 | 0.29 |
Capex / Sales | 0.51% | 0.09% | 0.06% | 1.17% | 3.09% | 6.45% |
Announcement Date | 9/13/18 | 9/27/19 | 9/30/20 | 9/29/21 | 9/29/22 | 8/29/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+41.67% | 24.77M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- RHT Stock
- Financials Resonance Health Limited